-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
HIV-1-inhibitor-40
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/hiv-1-inhibitor-40.gif)
| Category | Human immunodeficiency Virus (HIV) |
| Description | HIV-1 inhibitor-40 (Compound 4ab) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 with an EC50 of 1.9 nM. HIV-1 inhibitor-40 displays weak CYP sensitivity with IC50 values of 5.16 μM and 4.51 μM against CYP2C9 and CYP2C19, respectively. HIV-1 inhibitor-40 has no apparent in vivo acute toxicity. |
Product Information
| Synonyms | NNRTI 4ab|NNRTI-4ab|HIV-1 inhibitor-40|GLXC-25838|HY-147807|4'-((6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3'-methoxy-[1,1'-biphenyl]-4-carbonitrile |
| Molecular Weight | 434.45 |
| Molecular Formula | C25H18N6O2 |
| Canonical SMILES | COC1=C(C=CC(=C1)C2=CC=C(C=C2)C#N)OC3=NC(=NC(=C3)N)NC4=CC=C(C=C4)C#N |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 715 |
| Exact Mass | 434.14912384 |
| In Vitro | HIV-1 inhibitor-40 (Compound 4ab) displays inhibitory activity with EC50 values of 0.019 ± 0.005, 0.004 ± 0.001, 0.029 ± 0.007, 0.570 ± 0.099 and 0.009 ± 0.006 μM against L100I, K103N, Y181C, Y188L and E138K HIV-1 mutant strains, respectively. |
| Target | HIV-1 (WT): 1.9 nM (EC50) HIV-1 (K103N): 0.004 μM (EC50) HIV-1 (E138K): 0.009 μM (EC50) HIV-1 (L100I)0: .019 μM (EC50) HIV-1 (Y181C): 0.029 μM (EC50) HIV-1 (Y188L): 0.570 μM (EC50) CYP2C19: 4.51 μM (IC50) CYP2C9: 5.16 μM (IC50) |
| XLogP3-AA | 4.6 |
